Founded at the Abramson Cancer Center at the University of Pennsylvania

Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma

Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma

JAMA Network Open │ 2019

Pengxiang Li; Jordan Jahnke; Amy R. Pettit; Yu-Ning Wong; Jalpa A. Doshi